GlaxoSmithKline

An organization that ClinicalTrials.gov lists as a sponsor or collaborator of 28 trials in this atlas.

  • Organization
  • In this atlas

Overview

Technical summary

Sponsor class industry. No ROR record matches the name exactly.

Trials at a glance

These figures count only the registry trials in this atlas that name GlaxoSmithKline as a sponsor: 28 trials, 25 as lead sponsor and 3 as collaborator.

Phase and status

Trials by phase and registry status
PhaseRecruitingActive, not recruitingCompletedTerminatedAll statuses
Phase 200718
Phase 31015016
Phase 401304
All phases1125128

Start year

Trials started per year
Start yearTrials
20261
20232
20181
20171
20166
20151
20143
20134
20121
20112
20106

Main countries

  • United States 21 trials
  • Canada 13 trials
  • Spain 13 trials
  • United Kingdom 13 trials
  • Germany 12 trials

Roles

  • Company
  • Sponsor

Sector

Industry

The registry's words

Labels as the registry gives them, not rewritten.

Sponsor name
GlaxoSmithKline
Sponsor class
INDUSTRY

Registry records

Assembled by a program from ClinicalTrials.gov. No person wrote or checked these pages, and they are counted apart from the pages that people wrote. Lists of trials come from the registry's own coding and may miss trials.

Registry trials 28

Record details

Record id
cardio:org-glaxosmithkline
Content hash
eb8fd249690216d2f451d92e5fb9041f4a7ab302053c48e44aa12892b7d1e4a8